The simplest and fastest Total Antibody (IgG, IgM, IgG) ELISA test for COVID-19.
Negotiable / Pieces | Min Order Quantity Unit
1 PlexenseSupplier Activity
tradeKorea provides seller activity to buyers through seller evaluation and measurement according to each item.
" Activity of supplier was updated in the "transaction" section of the last 5 days ago"
Country South Korea
|Product name||ACCEL ELISA COVID19 TEST KIT||Certification||CE|
|category||Medical Test Kit||Ingredients||-|
|Keyword||corona , serology , testing kit , covid19||Unit Size||158.0 * 93.0 * 103.0 mm|
|Brand name||ACCEL ELISA COVID19 test kit||Unit Weigh||250 g|
|Supply type||OEM,ODM,Availible||HS code||382200|
ACCEL ELISA® COVID-19 Total Antibody Kit
This test kit is a serology-based SARS-CoV-2 total antibody detection assay which utilizes Plexense’s proven and patented ACCEL ELISA® technology for sensitive, rapid and accurate results.
The ACCEL ELISA® COVID-19 assay uses the SARS-CoV-2 nucleocapsid protein (N-protein) developed by the BioNano Health Guard Research Center (a division of the Ministry of Science and ICT, Korea) in collaboration with Korea Research Institute of Bioscience and Biotechnology (KRIBB) for the sole use of COVID-19 antibody detection on ACCEL ELISA® platform.
The ACCEL ELISA® has greatly simplified the tedious process of conventional ELISA test method through its patented well-design technology. Now, laboratories and test centers worldwide have the option of selecting and deploying ELISA tests across all their facilities without the need for exotic equipment. Each ACCEL ELISA® COVID-19 kit can test up to 94 patient samples simultaneously in just under 30 minutes. In terms of daily testing capacity, ramping up to 3,000 or even 10,000 tests per day is as simple as adding clinical staff and basic laboratory instruments. It is that simple and quick, and all possible due to the new ACCEL ELISA® technology.
In terms of accuracy, ACCEL ELISA® COVID-19 Kit has a 98.5% overall agreement to real time PCR testing method. At the heart of Plexense’s ACCEL ELISA® technology is the precision-cut “starburst” design. This was designed with the intent to improve antibody capture from any angle within the well and optimize surface chemistry for higher sensitivity and better performance. Based on recent clinical assessment of 341 patient samples shows that the ACCEL ELISA® COVID-19 Kit performed at a sensitivity of 100% and a specificity of 100% for patients with 5 or more days onset of infection.
Why choose ACCEL ELISA® over other platforms?
·Quick testing turnaround for the detection of total antibodies (IgA, IgM, IgG) against SARS-Cov-2 antigens
·Highly improved sensitivity over lateral flow (immunochromatography) method
·High-throughput testing available up to 94 patient samples at a single run ·96-well strip plate formatted
·Compatible with standard plate reader (OD read at 650nm)
·Sample type & volume required per well: 10 μL human blood serum
·30 minutes Assay time
·Validation of assay with 341 patient sera samples confirmed high accuracy results –Sensitivity 94.4%, Specificity 100%, Overall Agreement with RT-PCR 98.5%
|Price (FOB)||Negotiable||transportation||Air Transportation|
|Payment Options||L/C,T/T||Shipping time||Negotiable|
We are Plexense Inc., a South Korean company that specializes in the development and production of a fast and cost-effective ELISA immunoassay platform for clinical, food and life science testing.
Currently we are focusing on diagnostic kits for the COVID-19.
Our kit is an advanced ELISA platform which is very cost-effective, patented technology that makes the accuracy of our product excellent.
If you have more questions about our diagnostic kit for the Covid-19, Please don’t hesitate to contact us or you also can visit our website: www.plexense.com to register your interest or review our product information.